Recycling of receptor-bound IgE by rat basophilic leukemia cells. 1986

K Furuichi, and J Rivera, and L M Buonocore, and C Isersky

Rat basophilic leukemia (RBL) cells have receptors for immunoglobulin E (IgE). We previously showed that unlike some other ligands, the binding of monomeric rat or mouse IgE to RBL cells does not induce endocytosis. However, aggregation of the cell-bound, monomeric mouse IgE anti-dinitrophenyl (DNP) with DNP-protein conjugates leads to endocytosis of the aggregated mouse IgE and to the co-endocytosis of some unaggregated monomeric rat IgE. In this study we analyzed and compared the fate of co-endocytosed and endocytosed IgE. We found that co-endocytosed rat IgE recycled back to the cell surface within 3 to 4 hr. In contrast, endocytosed, immunochemically cross-linked, receptor-bound mouse IgE anti-DNP was partially degraded and was released into the medium, with no observable recycling of receptors, by 3 hr. However, addition of the hapten, DNP-lysine, resulted in rapid recycling (t1/2 10 min) of the endocytosed receptor-bound IgE to the plasma membrane and blocked additional endocytosis. Recycling of the endocytosed mouse IgE was more pronounced when the hapten was added to cells within 20 min of the initiation of endocytosis. When the hapten was added to the cells at later times (60 to 180 min), progressively less IgE recycled to the surface. This may reflect shuttling of the internalized IgE from a 'prelysosomal' to a 'lysosomal' compartment. Thus we provide evidence for recycling of monomeric IgE receptor complexes, sorting between cross-linked and non-cross-linked IgE receptor complexes, the freeing of receptor-bound monomeric IgE from the endocytosed immune-complexed IgE, and the apparent dependence of the recycling efficiency upon intracellular localization.

UI MeSH Term Description Entries
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D011947 Receptors, Antigen, B-Cell IMMUNOGLOBULINS on the surface of B-LYMPHOCYTES. Their MESSENGER RNA contains an EXON with a membrane spanning sequence, producing immunoglobulins in the form of type I transmembrane proteins as opposed to secreted immunoglobulins (ANTIBODIES) which do not contain the membrane spanning segment. Antigen Receptors, B-Cell,B-Cell Antigen Receptor,B-Cell Antigen Receptors,Surface Immunoglobulin,Immunoglobulins, Membrane-Bound,Immunoglobulins, Surface,Membrane Bound Immunoglobulin,Membrane-Bound Immunoglobulins,Receptors, Antigen, B Cell,Surface Immunoglobulins,Antigen Receptor, B-Cell,Antigen Receptors, B Cell,B Cell Antigen Receptor,B Cell Antigen Receptors,Bound Immunoglobulin, Membrane,Immunoglobulin, Membrane Bound,Immunoglobulin, Surface,Immunoglobulins, Membrane Bound,Membrane Bound Immunoglobulins,Receptor, B-Cell Antigen,Receptors, B-Cell Antigen
D011961 Receptors, Fc Molecules found on the surface of some, but not all, B-lymphocytes, T-lymphocytes, and macrophages, which recognize and combine with the Fc (crystallizable) portion of immunoglobulin molecules. Fc Receptors,Fc Receptor,Receptor, Fc
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003432 Cross-Linking Reagents Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. Bifunctional Reagent,Bifunctional Reagents,Cross Linking Reagent,Crosslinking Reagent,Cross Linking Reagents,Crosslinking Reagents,Linking Reagent, Cross,Linking Reagents, Cross,Reagent, Bifunctional,Reagent, Cross Linking,Reagent, Crosslinking,Reagents, Bifunctional,Reagents, Cross Linking,Reagents, Cross-Linking,Reagents, Crosslinking
D004136 Dinitrobenzenes Benzene derivatives which are substituted with two nitro groups in the ortho, meta or para positions. Dinitrobenzene,Dinitrophenyl Compound,Dinitrophenyl Compounds,Dinitrotoluene,Dinitrotoluenes,Compound, Dinitrophenyl
D004140 Dinitrophenols Organic compounds that contain two nitro groups attached to a phenol.
D004705 Endocytosis Cellular uptake of extracellular materials within membrane-limited vacuoles or microvesicles. ENDOSOMES play a central role in endocytosis. Endocytoses

Related Publications

K Furuichi, and J Rivera, and L M Buonocore, and C Isersky
May 1979, Journal of immunology (Baltimore, Md. : 1950),
K Furuichi, and J Rivera, and L M Buonocore, and C Isersky
August 1987, The Journal of cell biology,
K Furuichi, and J Rivera, and L M Buonocore, and C Isersky
May 1987, European journal of immunology,
K Furuichi, and J Rivera, and L M Buonocore, and C Isersky
June 1989, Journal of immunology (Baltimore, Md. : 1950),
K Furuichi, and J Rivera, and L M Buonocore, and C Isersky
July 1983, Journal of immunology (Baltimore, Md. : 1950),
K Furuichi, and J Rivera, and L M Buonocore, and C Isersky
January 1981, Kroc Foundation series,
K Furuichi, and J Rivera, and L M Buonocore, and C Isersky
October 1988, The Tohoku journal of experimental medicine,
K Furuichi, and J Rivera, and L M Buonocore, and C Isersky
July 2006, Journal of immunology (Baltimore, Md. : 1950),
K Furuichi, and J Rivera, and L M Buonocore, and C Isersky
March 1986, Agents and actions,
Copied contents to your clipboard!